.jpg)
.png)
Potpourri 2015
This issue sponsored by the National Lipid Association Featuring: “The Impact of Gilbert's Syndrome on Atherosclerosis” and "Dyslipidemia, Cardiovascular Disease, and Youth with Diabetes" more
Patients with chronic kidney disease (CKD) including those undergoing dialysis have an increased risk of premature cardiovascular disease (CVD).1 CKD patients also have a high rate of coronary death and myocardial infarction — rates equivalent to those of diabetics. CKD, per se, has thus been... more
Introduction The development and use of antiretroviral medications to treat patients infected with HIV have dramatically changed the course of this disease from one that was fatal to a chronic and more manageable condition. However, with antiretroviral therapy (ART) came a new spectrum of... more
After the clinical studies, Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes (AIM-HIGH) and Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE), the National Lipid Association... more
Author Edwin Ferguson, MD, is a 70-year-old practicing preventive cardiologist and certified clinical lipidologist who, despite 20 years of treatment for dyslipidemia, recently had an ST elevation myocardial infarction (STEMI). His cardiovascular journey began in medical school when, despite his... more
The Foundation of the National Lipid Association continues to make strides to help educate and promote clinical lipidology — both to clinicians and to the public. In the last Foundation Update, we discussed the launch of “Cholesterol Counts,” an unbranded cholesterol awareness campaign geared... more
“Skate to where the puck is going to be, not to where it has been.” Wayne Gretzky As I write this last president’s letter for the annual Potpourri edition of the LipidSpin, I’m reminded of how fortunate I’ve been to serve as the President of the National Lipid Association (NLA) during the past... more
The National Lipid Association (NLA) is proud to move forward with its Recommendations for Patient-Centered Management of Dyslipidemia for those practicing clinical lipidology in an environment where many clinical queries remain unanswered for clinicians. To that end, the NLA has developed Part II... more
The greater danger for most of us lies not in setting our aim too high and falling short; but in setting our aim too low, and achieving our mark.” Michelangelo Buonarroti Along with the NLA Scientific Sessions, the summer also brings the anticipation of the Prescription Drug User Fee Act (... more
Although low-density lipoprotein cholesterol (LDL-C) lowering with statin therapy has been part of the National Cholesterol Education Program guidelines for 26 years, significant residual cardiovascular risk remains in both primary- and secondary-prevention patients. This residual risk is... more